The date of event and implant is estimated to be (b)(6) 2015.There was no reported device malfunction and the product was not returned.A review of the lot history record for the reported lot could not be conducted because the part and lot numbers were not provided.The reported potential adverse events of myocardial infarction and thrombosis are listed in the absorb bioresorbable vascular scaffold system (bvss), instructions for use (ifu) as known adverse events associated with the use of a coronary scaffold.A conclusive cause for the reported patient effects and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.The patient deaths referenced are being filed on a separate medwatch report #.Literature.¿article title- predictors of long-term adverse events after absorb bioresorbable vascular scaffold implantation: a 1,933-patient pooled analysis from international registries".
|
It was reported through a research article identifying the absorb scaffold that may be related to death and serious injury.Specific patient information is documented as unknown.Details are listed in the article, titled, predictors of long-term adverse events after absorb bioresorbable vascular scaffold implantation: a 1,933-patient pooled analysis from international registries.
|